Progress and perspectives on targeting nanoparticles for brain drug delivery

Acta Pharmaceutica Sinica B

Volumn 6, Issue 4, 2016, Pages 268-286

  Gao, Huile ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Blood brain barrier; Brain targeting; Dual targeting; Intranasal delivery; Nanoparticles

Indexed keywords

AGGLUTININ; APOLIPOPROTEIN; APTAMER; BOVINE SERUM ALBUMIN; CELL PENETRATING PEPTIDE; DOCETAXEL; GLUCOSE TRANSPORTER; GLUTATHIONE; HYBRID PROTEIN; INTERLEUKIN 13; LACTOFERRIN; LAPATINIB; NANOPARTICLE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ASTROCYTE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BLOOD BRAIN TUMOR BARRIER; BRAIN; BRAIN CELL; BRAIN TUMOR; CELLULAR PARAMETERS; CYTOARCHITECTURE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG TARGETING; DRUG TRANSPORT; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; FOCUSED ULTRASOUND; INTERNALIZATION; INTRANASAL DRUG ADMINISTRATION; NERVE CELL; NEUROTOXICITY; NOSE CAVITY; NOSE TO BRAIN BARRIER; OLFACTORY BULB; OLFACTORY EPITHELIUM; PERICYTE; PERMEABILITY BARRIER; PHAGE DISPLAY; PROTEIN EXPRESSION; REVIEW; TIGHT JUNCTION; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; ULTRASOUND; VASCULAR AMYLOIDOSIS;

EID: 85006235034     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2016.05.013     Document Type: Review

References (238)

1. 1 Srikanth, M., Kessler, J.A., Nanotechnology-novel therapeutics for CNS disorders. Nat Rev Neurol 8 (2012), 307–318.
2. 2 Gao, H.L., Pang, Z.Q., Jiang, X.G., Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm Res 30 (2013), 2485–2498.
3. 3 Wohlfart, S., Gelperina, S., Kreuter, J., Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release 161 (2012), 264–273.
4. 4 Pardridge, W.M., Drug targeting to the brain. Pharm Res 24 (2007), 1733–1744.
5. 5 Pardridge, W.M., CNS drug design based on principles of blood–brain barrier transport. J Neurochem 70 (1998), 1781–1792.
6. 6 Alyautdin, R., Khalin, I., Nafeeza, M.I., Haron, M.H., Kuznetsov, D., Nanoscale drug delivery systems and the blood–brain barrier. Int J Nanomedicine 9 (2014), 795–811.
7. 7 Eyal, S., Hsiao, P., Unadkat, J.D., Drug interactions at the blood–brain barrier: fact or fantasy?. Pharmacol Ther 123 (2009), 80–104.
8. 8 Bhowmik, A., Khan, R., Ghosh, M.K., Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int, 2015, 2015, 320941.
9. 9 Posadas, I., Monteagudo, S., Ceña, V., Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis. Nanomedicine (London) 11 (2016), 833–849.
10. 10 Butt, A.M., Jones, H.C., Abbott, N.J., Electrical resistance across the blood–brain barrier in anaesthetized rats: a developmental study. J Physiol 429 (1990), 47–62.
11. 11 Gao, H.L., Jiang, X.G., Progress on the diagnosis and evaluation of brain tumors. Cancer Imaging 13 (2013), 466–481.
12. 12 Guo, L.R., Ren, J.F., Jiang, X.G., Perspectives on brain-targeting drug delivery systems. Curr Pharm Biotechnol 13 (2012), 2310–2318.
13. 13 Agarwal, S., Sane, R., Oberoi, R., Ohlfest, J.R., Elmquist, W.F., Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med, 13, 2011, e17.
14. 14 Wolburg, H., Noell, S., Fallier-Becker, P., Mack, A.F., Wolburg-Buchholz, K., The disturbed blood–brain barrier in human glioblastoma. Mol Aspects Med 33 (2012), 579–589.
15. 15 Agarwal, S., Manchanda, P., Vogelbaum, M.A., Ohlfest, J.R., Elmquist, W.F., Function of the blood–brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma. Drug Metab Dispos 41 (2013), 33–39.
16. 16 Taskar, K.S., Rudraraju, V., Mittapalli, R.K., Samala, R., Thorsheim, H.R., Lockman, J., et al. Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. Pharm Res 29 (2012), 770–781.
17. 17 Bronger, H., König, J., Kopplow, K., Steiner, H.H., Ahmadi, R., Herold-Mende, C., et al. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood–tumor barrier. Cancer Res 65 (2005), 11419–11428.
18. 18 Groothuis, D.R., The blood–brain and blood–tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2 (2000), 45–59.
19. 19 Roberts, W.G., Delaat, J., Nagane, M., Huang, S., Cavenee, W.K., Palade, G.E., Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 153 (1998), 1239–1248.
20. 20 Karim, R., Palazzo, C., Evrard, B., Piel, G., Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. J Control Release 227 (2016), 23–37.
21. 21 Mohri, M., Nitta, H., Yamashita, J., Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neurooncol 49 (2000), 105–115.
22. 22 Fattori, S., Becherini, F., Cianfriglia, M., Parenti, G., Romanini, A., Castagna, M., Human brain tumors: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells. Virchows Arch 451 (2007), 81–87.
23. 23 Sarin, H., Kanevsky, A.S., Wu, H., Sousa, A.A., Wilson, C.M., Aronova, M.A., et al. Physiologic upper limit of pore size in the blood–tumor barrier of malignant solid tumors. J Transl Med, 7, 2009, 51.
24. 24 Djupesland, P.G., Messina, J.C., Mahmoud, R.A., The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. Ther Deliv 5 (2014), 709–733.
25. 25 Wu, H.B., Hu, K.L., Jiang, X.G., From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv 5 (2008), 1159–1168.
26. 26 Qian, Z.M., Li, H.Y., Sun, H.Z., Ho, K., Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54 (2002), 561–587.
27. 27 Xin, H.L., Sha, X.Y., Jiang, X.Y., Zhang, W., Chen, L.C., Fang, X.L., Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials 33 (2012), 8167–8176.
28. 28 Kumar, P., Wu, H.Q., McBride, J.L., Jung, K.E., Kim, M.H., Davidson, B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448 (2007), 39–43.
29. 29 Pardridge, W.M., blood–brain barrier delivery. Drug Discov Today 12 (2007), 54–61.
30. 30 Zhang, T.T., Li, W., Meng, G.M., Wang, P., Liao, W.Z., Strategies for transporting nanoparticles across the blood–brain barrier. Biomater Sci 4 (2016), 219–229.
31. 31 Cannon, R.E., Peart, J.C., Hawkins, B.T., Campos, C.R., Miller, D.S., Targeting blood–brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proc Natl Acad Sci U S A 109 (2012), 15930–15935.
32. 32 Hsu, S.H., Wen, C.J., Al-Suwayeh, S.A., Chang, H.W., Yen, T.C., Fang, J.Y., Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Nanotechnology, 21, 2010, 405101.
33. 33 Gorin, F., Harley, W., Schnier, J., Lyeth, B., Jue, T., Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft. Acta Neuropathol 107 (2004), 235–244.
34. 34 Li, L., Di, X.S., Zhang, S.W., Kan, Q.M., Liu, H., Lu, T.S., et al. Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting. Colloids Surf B Biointerfaces 141 (2016), 260–267.
35. 35 Geldenhuys, W.J., Allen, D.D., The blood–brain barrier choline transporter. Cent Nerv Syst Agents Med Chem 12 (2012), 95–99.
36. 36 Pang, Z.Q., Gao, H.L., Yu, Y., Guo, L.R., Chen, J., Pan, S.Q., et al. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjug Chem 22 (2011), 1171–1180.
37. 37 Pang, Z.Q., Gao, H.L., Yu, Y., Chen, J., Guo, L.R., Ren, J.F., et al. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Int J Pharm 415 (2011), 284–292.
38. 38 Cui, Y.N., Xu, Q.X., Chow, P.K., Wang, D.P., Wang, C.H., Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 34 (2013), 8511–8520.
39. 39 Pang, Z.Q., Lu, W., Gao, H.L., Hu, K.L., Chen, J., Zhang, C.L., et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Release 128 (2008), 120–127.
40. 40 Kim, S.S., Rait, A., Kim, E., Pirollo, K.F., Nishida, M., Farkas, N., et al. A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival. ACS Nano 8 (2014), 5494–5514.
41. 41 Salvati, E., Re, F., Sesana, S., Cambianica, I., Sancini, G., Masserini, M., et al. Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model. Int J Nanomedicine 8 (2013), 1749–1758.
42. 42 Wu, D., Yang, J., Pardridge, W.M., Drug targeting of a peptide radiopharmaceutical through the primate blood–brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest 100 (1997), 1804–1812.
43. 43 Dieu, L.H., Wu, D.L., Palivan, C.G., Balasubramanian, V., Huwyler, J., Polymersomes conjugated to 83−14 monoclonal antibodies: in vitro targeting of brain capillary endothelial cells. Eur J Pharm Biopharm 88 (2014), 316–324.
44. 44 Fillebeen, C., Descamps, L., Dehouck, M.P., Fenart, L., Benaïssa, M., Spik, G., et al. Receptor-mediated transcytosis of lactoferrin through the blood–brain barrier. J Biol Chem 274 (1999), 7011–7017.
45. 45 Ji, B., Maeda, J., Higuchi, M., Inoue, K., Akita, H., Harashima, H., et al. Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci 78 (2006), 851–855.
46. 46 Hu, K.L., Li, J.W., Shen, Y.H., Lu, W., Gao, X.L., Zhang, Q.Z., et al. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release 134 (2009), 55–61.
47. 47 Ye, Y.J., Sun, Y., Zhao, H.L., Lan, M.B., Gao, F., Song, C., et al. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery. Int J Pharm 458 (2013), 110–117.
48. 48 Hu, K.L., Shi, Y.B., Jiang, W.M., Han, J.Y., Huang, S.X., Jiang, X.G., Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson׳s disease. Int J Pharm 415 (2011), 273–283.
49. 49 Yu, Y., Jiang, X.G., Gong, S.Y., Feng, L., Zhong, Y.Q., Pang, Z.Q., The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood–brain barrier after modification with lactoferrin. Nanoscale 6 (2014), 3250–3258.
50. 50 Zhan, C.Y., Li, B., Hu, L.J., Wei, X.L., Feng, L.Y., Fu, W., et al. Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine receptor ligand. Angew Chem Int Ed Engl 50 (2011), 5482–5485.
51. 51 Huo, H., Gao, Y.K., Wang, Y., Zhang, J.H., Wang, Z.Y., Jiang, T.Y., et al. Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain. J Colloid Interface Sci 447 (2015), 8–15.
52. 52 Liu, Y., An, S., Li, J.F., Kuang, Y.Y., He, X., Guo, Y.B., et al. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer׳s disease mice. Biomaterials 80 (2016), 33–45.
53. 53 Park, T.E., Singh, B., Li, H.S., Lee, J.Y., Kang, S.K., Choi, Y.J., et al. Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer׳s disease. Biomaterials 38 (2015), 61–71.
54. 54 Yu, X.R., Wang, J.H., Liu, J.S., Shen, S., Cao, Z.L., Pan, J.W., et al. A multimodal pepstatin A peptide-based nanoagent for the molecular imaging of P-glycoprotein in the brains of epilepsy rats. Biomaterials 76 (2016), 173–186.
55. 55 Lee, J.H., Engler, J.A., Collawn, J.F., Moore, B.A., Receptor mediated uptake of peptides that bind the human transferrin receptor. Eur J Biochem 268 (2001), 2004–2012.
56. 56 Kuang, Y.Y., An, S., Guo, Y.B., Huang, S.X., Shao, K., Liu, Y., et al. T7 peptide–functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Int J Pharm 454 (2013), 11–20.
57. 57 Dixit, S., Novak, T., Miller, K., Zhu, Y., Kenney, M.E., Broome, A.M., Transferrin receptor–targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale 7 (2015), 1782–1790.
58. 58 Cheng, C.S., Chen, Y.H., Lennox, K.A., Behlke, M.A., Davidson, B.L., In vivo SELEX for identification of brain-penetrating aptamers. Mol Ther Nucleic Acids, 2, 2013, e67.
59. 59 Dehouck, B., Dehouck, M.P., Fruchart, J.C., Cecchelli, R., Upregulation of the low density lipoprotein receptor at the blood–brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J Cell Biol 126 (1994), 465–473.
60. 60 Dehouck, B., Fenart, L., Dehouck, M.P., Pierce, A., Torpier, G., Cecchelli, R., A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J Cell Biol 138 (1997), 877–889.
61. 61 Re, F., Cambianica, I., Zona, C., Sesana, S., Gregori, M., Rigolio, R., et al. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood–brain barrier model. Nanomedicine 7 (2011), 551–559.
62. 62 Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Büchel, C., et al. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood–brain barrier and enter the rodent brain. J Drug Target 18 (2010), 842–848.
63. 63 Tamaru, M., Akita, H., Nakatani, T., Kajimoto, K., Sato, Y., Hatakeyama, H., et al. Application of apolipoprotein E–modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain. Int J Nanomedicine 9 (2014), 4267–4276.
64. 64 Jose, S., Sowmya, S., Cinu, T.A., Aleykutty, N.A., Thomas, S., Souto, E.B., Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Eur J Pharm Sci 63 (2014), 29–35.
65. 65 Tamaru, M., Akita, H., Kajimoto, K., Sato, Y., Hatakeyama, H., Harashima, H., An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells. Int J Pharm 465 (2014), 77–82.
66. 66 Wong, H.L., Wu, X.Y., Bendayan, R., Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliv Rev 64 (2012), 686–700.
67. 67 Gao, K.P., Jiang, X.G., Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm 310 (2006), 213–219.
68. 68 Tian, X.H., Lin, X.N., Wei, F., Feng, W., Huang, Z.C., Wang, P., et al. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine 6 (2011), 445–452.
69. 69 Martins, S., Sarmento, B., Nunes, C., Lucio, M., Reis, S., Ferreira, D., Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur J Pharm Biopharm 85 (2013), 488–502.
70. 70 Wilson, B., Lavanya, Y., Priyadarshini, S.R., Ramasamy, M., Jenita, J.L., Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies. Int J Pharm 473 (2014), 73–79.
71. 71 Shalviri, A., Chan, H.K., Raval, G., Abdekhodaie, M.J., Liu, Q., Heerklotz, H., et al. Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin. Colloids Surf B Biointerfaces 101 (2013), 405–413.
72. 72 Li, J., Cai, P., Shalviri, A., Henderson, J.T., He, C.S., Foltz, W.D., et al. A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood–brain barrier targeting brain metastases of breast cancer. ACS Nano 8 (2014), 9925–9940.
73. 73 Wei, X.L., Chen, X.S., Ying, M., Lu, W.Y., Brain tumor–targeted drug delivery strategies. Acta Pharm Sin B 4 (2014), 193–201.
74. 74 Gaillard, P.J., Visser, C.C., Appeldoorn, C.C.M., Rip, J., Enhanced brain drug delivery: safely crossing the blood–brain barrier. Drug Discov Today: Technol 9 (2012), e155–e160.
75. 75 Rip, J., Chen, L.D., Hartman, R., van den Heuvel, A., Reijerkerk, A., van Kregten, J., et al. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats. J Drug Target 22 (2014), 460–467.
76. 76 Gaillard, P.J., Appeldoorn, C.C., Rip, J., Dorland, R., van der Pol, S.M., Kooij, G., et al. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Release 164 (2012), 364–369.
77. 77 de Boer, M., Visser, C.C., Gaillard, P.J., Upcycling drugs for brain-related diseases: a sustainable future for targeted drug delivery. Ther Deliv 4 (2013), 435–438.
78. 78 Rotman, M., Welling, M.M., Bunschoten, A., de Backer, M.E., Rip, J., Nabuurs, R.J., et al. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer׳s disease. J Control Release 203 (2015), 40–50.
79. 79 Gaillard, P.J., Visser, C.C., Appeldoorn, C.C., Rip, J., Targeted blood-to-brain drug delivery-10 key development criteria. Curr Pharm Biotechnol 13 (2012), 2328–2339.
80. 80 Tan, H.B., Chen, L.M., Guan, Y.H., Lin, X.T., Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy. Clin Nucl Med 36 (2011), 978–981.
81. 81 Li, J.F., Zhou, L., Ye, D.Y., Huang, S.X., Shao, K., Huang, R.Q., et al. Choline-derivate-modified nanoparticles for brain-targeting gene delivery. Adv Mater 23 (2011), 4516–4520.
82. 82 Li, J.F., Huang, S.X., Shao, K., Liu, Y., An, S., Kuang, Y.Y., et al. A choline derivate-modified nanoprobe for glioma diagnosis using MRI. Sci Rep, 3, 2013, 1623.
83. 83 Li, J.F., Guo, Y.B., Kuang, Y.Y., An, S., Ma, H.J., Jiang, C., Choline transporter-targeting and co-delivery system for glioma therapy. Biomaterials 34 (2013), 9142–9148.
84. 84 Lu, W., Zhang, Y., Tan, Y.Z., Hu, K.L., Jiang, X.G., Fu, S.K., Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107 (2005), 428–448.
85. 85 Lu, W., Wan, J., She, Z.J., Jiang, X.G., Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release 118 (2007), 38–53.
86. 86 Xu, F., Lu, W., Wu, H.B., Fan, L., Gao, X.L., Jiang, X.G., Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles. J Drug Target 17 (2009), 423–434.
87. 87 Xie, Y.L., Lu, W., Jiang, X.G., Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Behav Brain Res 173 (2006), 76–84.
88. 88 Lu, W., Wan, J., Zhang, Q., She, Z.J., Jiang, X.G., Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats. Int J Cancer 120 (2007), 420–431.
89. 89 Lu, W., Sun, Q., Wan, J., She, Z.J., Jiang, X.G., Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 66 (2006), 11878–11887.
90. 90 Bechara, C., Sagan, S., Cell-penetrating peptides: 20 years later, where do we stand?. FEBS Lett 587 (2013), 1693–1702.
91. 91 Sawant, R., Torchilin, V., Intracellular delivery of nanoparticles with CPPs. Methods Mol Biol 683 (2011), 431–451.
92. 92 Qin, Y., Chen, H.L., Yuan, W.M., Kuai, R., Zhang, Q.Y., Xie, F.L., et al. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 419 (2011), 85–95.
93. 93 Qin, Y., Zhang, Q.Y., Chen, H.L., Yuan, W.M., Kuai, R., Xie, F.L., et al. Comparison of four different peptides to enhance accumulation of liposomes into the brain. J Drug Target 20 (2012), 235–245.
94. 94 Malhotra, M., Tomaro-Duchesneau, C., Prakash, S., Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials 34 (2013), 1270–1280.
95. 95 Cheng, Y., Dai, Q., Morshed, R.A., Fan, X.B., Wegscheid, M.L., Wainwright, D.A., et al. Blood–brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging. Small 10 (2014), 5137–5150.
96. 96 Gao, H.L., Zhang, Q.Y., Yu, Z.Q., He, Q., Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery. Curr Pharm Biotechnol 15 (2014), 210–219.
97. 97 Herce, H.D., Garcia, A.E., Cardoso, M.C., Fundamental molecular mechanism for the cellular uptake of guanidinium-rich molecules. J Am Chem Soc 136 (2014), 17459–17467.
98. 98 Koren, E., Torchilin, V.P., Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18 (2012), 385–393.
99. 99 Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., Harashima, H., Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J Control Release 153 (2011), 141–148.
100. 100 Sharma, G., Modgil, A., Sun, C., Singh, J., Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood–brain barrier model. J Pharm Sci 101 (2012), 2468–2478.
101. 101 Sharma, G., Modgil, A., Layek, B., Arora, K., Sun, C., Law, B., et al. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection. J Control Release 167 (2013), 1–10.
102. 102 Liu, Y.Y., Ran, R., Chen, J.T., Kuang, Q.F., Tang, J., Mei, L., et al. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 35 (2014), 4835–4847.
103. 103 Bhatia, S.P., McGinty, D., Letizia, C.S., Api, A.M., Fragrance material review on l-borneol. Food Chem Toxicol, 46, 2008 suppl 11:S81–4.
104. 104 Zhang, L., Han, L.M., Qin, J., Lu, W.Y., Wang, J.X., The use of borneol as an enhancer for targeting aprotinin-conjugated PEG–PLGA nanoparticles to the brain. Pharm Res 30 (2013), 2560–2572.
105. 105 Toman, P., Lien, C.F., Ahmad, Z., Dietrich, S., Smith, J.R., An, Q., et al. Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: preparation and in vitro investigation. Acta Biomater 23 (2015), 250–262.
106. 106 Jacobson, K.A., Gao, Z.G., Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5 (2006), 247–264.
107. 107 Sachdeva, S., Gupta, M., Adenosine and its receptors as therapeutic targets: an overview. Saudi Pharm J 21 (2013), 245–253.
108. 108 Carman, A.J., Mills, J.H., Krenz, A., Kim, D.G., Bynoe, M.S., Adenosine receptor signaling modulates permeability of the blood–brain barrier. J Neurosci 31 (2011), 13272–13280.
109. 109 Gao, X.H., Qian, J., Zheng, S.Y., Changyi, Y.Z., Zhang, J.P., Ju, S.H., et al. Overcoming the blood–brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. ACS Nano 8 (2014), 3678–3689.
110. 110 Zhang, F., Xu, C.L., Liu, C.M., Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma. Drug Des Devel Ther 9 (2015), 2089–2100.
111. 111 Etame, A.B., Diaz, R.J., O׳Reilly, M.A., Smith, C.A., Mainprize, T.G., Hynynen, K., et al. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine 8 (2012), 1133–1142.
112. 112 Aryal, M., Vykhodtseva, N., Zhang, Y.Z., Park, J., McDannold, N., Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model. J Control Release 169 (2013), 103–111.
113. 113 Liu, H.L., Hua, M.Y., Yang, H.W., Huang, C.Y., Chu, P.C., Wu, J.S., et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 107 (2010), 15205–15210.
114. 114 Aryal, M., Vykhodtseva, N., Zhang, Y.Z., McDannold, N., Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood–brain barrier disruption: a safety study. J Control Release 204 (2015), 60–69.
115. 115 Vykhodtseva, N., McDannold, N., Hynynen, K., Progress and problems in the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics 48 (2008), 279–296.
116. 116 Chen, H., Chen, C.C., Acosta, C., Wu, S.Y., Sun, T., Konofagou, E.E., A new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug delivery. PLoS One, 9, 2014, e108880.
117. 117 Illum, L., Nasal drug delivery-recent developments and future prospects. J Control Release 161 (2012), 254–263.
118. 118 Zhang, Q.Z., Jiang, X.G., Jiang, W.M., Lu, W., Su, L.N., Shi, Z.Q., Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 275 (2004), 85–96.
119. 119 Zheng, X.Y., Shao, X.Y., Zhang, C., Tan, Y.Z., Liu, Q.F., Wan, X., et al. Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer׳s disease. Pharm Res 32 (2015), 3837–3849.
120. 120 Dalpiaz, A., Ferraro, L., Perrone, D., Leo, E., Iannuccelli, V., Pavan, B., et al. Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles. Mol Pharm 11 (2014), 1550–1561.
121. 121 Sharma, D., Sharma, R.K., Sharma, N., Gabrani, R., Sharma, S.K., Ali, J., et al. Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS PharmSciTech 16 (2015), 1108–1121.
122. 122 Baba, M., Itaka, K., Kondo, K., Yamasoba, T., Kataoka, K., Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles. J Control Release 201 (2015), 41–48.
123. 123 Gao, X.L., Wu, B.X., Zhang, Q.Z., Chen, J., Zhu, J.H., Zhang, W.W., et al. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J Control Release 121 (2007), 156–167.
124. 124 Liu, Q.F., Shen, Y.H., Chen, J., Gao, X.L., Feng, C.C., Wang, L., et al. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles. Pharm Res 29 (2012), 546–558.
125. 125 Wen, Z.Y., Yan, Z.Q., Hu, K.L., Pang, Z.Q., Cheng, X.F., Guo, L.R., et al. Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson׳s disease following intranasal administration. J Control Release 151 (2011), 131–138.
126. –-treated rats following intranasal administration. Eur J Pharm Biopharm 80 (2012), 368–378.
127. 127 Chen, J., Zhang, C., Liu, Q.F., Shao, X.Y., Feng, C.C., Shen, Y.H., et al. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. J Drug Target 20 (2012), 174–184.
128. 128 Kamei, N., Takeda-Morishita, M., Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides. J Control Release 197 (2015), 105–110.
129. 129 Yan, L., Wang, H.Y., Jiang, Y.F., Liu, J.H., Wang, Z., Yang, Y.X., et al. Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery. Macromolecul Res 21 (2013), 435–441.
130. 130 Taki, H., Kanazawa, T., Akiyama, F., Takashima, Y., Okada, H., Intranasal delivery of camptothecin-loaded Tat-modified nanomicells for treatment of intracranial brain tumors. Pharmaceutics 5 (2012), 1092–1102.
131. 131 Gao, H.L., Pang, Z.Q., Pan, S.Q., Cao, S.J., Yang, Z., Chen, C., et al. Anti-glioma effect and safety of docetaxel-loaded nanoemulsion. Arch Pharm Res 35 (2012), 333–341.
132. 132 Gao, H.L., Cao, S.J., Yang, Z., Zhang, S., Pang, Z.Q., Jiang, X.G., Preparation, characterization and anti-glioma effects of docetaxel-loaded, lipoprotein-like nanoparticles. J Biomed Nanotech 11 (2015), 2137–2147.
133. 133 Gao, H.L., Wang, Y.C., Chen, C., Chen, J., Wei, Y., Cao, S.L., et al. Incorporation of lapatinib into core–shell nanoparticles improves both the solubility and anti-glioma effects of the drug. Int J Pharm 461 (2014), 478–488.
134. 134 Guo, L.R., Fan, L., Pang, Z.Q., Ren, J.F., Ren, Y.L., Li, J.W., et al. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes. J Control Release 154 (2011), 93–102.
135. 135 Kozielski, K.L., Tzeng, S.Y., De Mendoza, B.A., Green, J.J., Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells. ACS Nano 8 (2014), 3232–3241.
136. 136 Ireson, C.R., Kelland, L.R., Discovery and development of anticancer aptamers. Mol Cancer Ther 5 (2006), 2957–2962.
137. 137 Hovanessian, A.G., Soundaramourty, C., El Khoury, D., Nondier, I., Svab, J., Krust, B., Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS One, 5, 2010, e15787.
138. 138 Guo, J.W., Gao, X.L., Su, L.N., Xia, H.M., Gu, G.Z., Pang, Z.Q., et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32 (2011), 8010–8020.
139. 139 Gao, H., Qian, J., Yang, Z., Pang, Z., Xi, Z., Cao, S., et al. Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy. Biomaterials 33 (2012), 6264–6272.
140. 140 Mintz, A., Gibo, D.M., Slagle-Webb, B., Christensen, N.D., Debinski, W., IL-13Rα2 is a glioma-restricted receptor for interleukin-13. Neoplasia 4 (2002), 388–399.
141. 141 Fillmore, H.L., Shultz, M.D., Henderson, S.C., Cooper, P., Broaddus, W.C., Chen, Z.J., et al. Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors. Nanomedicine (London) 6 (2011), 449–458.
142. 142 Gao, H.L., Yang, Z., Zhang, S., Cao, S.J., Pang, Z.Q., Jiang, X.G., Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep, 3, 2013, 2534.
143. 143 Gao, H.L., Yang, Z., Zhang, S., Cao, S.J., Pang, Z.Q., Yang, X., et al. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. J Control Release 172 (2013), 921–928.
144. 144 Gao, H.L., Zhang, S., Yang, Z., Cao, S.J., Jiang, X.G., Pang, Z.Q., In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Int J Pharm 466 (2014), 8–17.
145. 145 Wang, B.Y., Lv, L.Y., Wang, Z.Y., Zhao, Y., Wu, L., Fang, X.L., et al. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2–mediated endocytosis. Biomaterials 35 (2014), 5897–5907.
146. 146 Wang, Y., Wang, K.Y., Zhao, J.F., Liu, X.G., Bu, J., Yan, X.Y., et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J Am Chem Soc 135 (2013), 4799–4804.
147. 3 expression and integrin-mediated signaling in glioma cells by adenvirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J Biol Chem 276 (2001), 47171–47177.
148. 148 Waite, C.L., Roth, C.M., PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. Bioconjug Chem 20 (2009), 1908–1916.
149. 3+-DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts. Adv Healthc Mater 2 (2013), 1501–1512.
150. 150 Zhan, C.Y., Gu, B., Xie, C., Li, J., Liu, Y., Lu, W.Y., Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release 143 (2010), 136–142.
151. 151 Miura, Y., Takenaka, T., Toh, K., Wu, S.R., Nishihara, H., Kano, M.R., et al. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood–brain tumor barrier. ACS Nano 7 (2013), 8583–8592.
152. 152 Wang, F.H., Zhang, W.J., Shen, Y.Y., Huang, Q., Zhou, D.J., Guo, S.R., Efficient RNA delivery by integrin-targeted glutathione responsive polyethyleneimine capped gold nanorods. Acta Biomater 23 (2015), 136–146.
153. 153 Wu, C.X., Lo, S.L., Boulaire, J., Hong, M.L., Beh, H.M., Leung, D.S., et al. A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro. J Control Release 130 (2008), 140–145.
154. 154 Wang, D.Y., Li, W.B., Zhang, H., Mao, Q.W., Xia, H.B., A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line. Oncol Rep 31 (2014), 2093–2098.
155. 155 Wild, J.R.L., Staton, C.A., Chapple, K., Corfe, B.M., Neuropilins: expression and roles in the epithelium. Int J Exp Pathol 93 (2012), 81–103.
156. 156 Wischhusen, J., Schneider, D., Mittelbronn, M., Meyermann, R., Engelmann, H., Jung, G., et al. Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system. J Neuroimmunol 162 (2005), 28–42.
157. 157 Deshane, J., Garner, C.C., Sontheimer, H., Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278 (2003), 4135–4144.
158. 158 Wang, C.W., Ning, L.P., Wang, H.W., Lu, Z.J., Li, X.G., Fan, X.Y., et al. A peptide-mediated targeting gene delivery system for malignant glioma cells. Int J Nanomedicine 8 (2013), 3631–3640.
159. 159 Yang, Y.Y., Yan, Z.Q., Wei, D.X., Zhong, J., Liu, L., Zhang, L., et al. Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes. Nanotechnology, 24, 2013, 405101.
160. 160 Shevtsov, M.A., Yakovleva, L.Y., Nikolaev, B.P., Marchenko, Y.Y., Dobrodumov, A.V., Onokhin, K.V., et al. Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma. Neuro Oncol 16 (2014), 38–49.
161. 161 Locatelli, E., Naddaka, M., Uboldi, C., Loudos, G., Fragogeorgi, E., Molinari, V., et al. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (London) 9 (2014), 839–849.
162. 162 Fang, C., Wang, K., Stephen, Z.R., Mu, Q.X., Kievit, F.M., Chiu, D.T., et al. Temozolomide nanoparticles for targeted glioblastoma therapy. ACS Appl Mater Interfaces 7 (2015), 6674–6682.
163. 163 Wang, J., Lei, Y., Xie, C., Lu, W.Y., Yan, Z.Q., Gao, J., et al. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex. Int J Pharm 458 (2013), 48–56.
164. 164 Chen, S.Q., Ahmadiantehrani, M., Publicover, N.G., Hunter, K.W. Jr, Zhu, X.S., Thermal decomposition based synthesis of Ag-In-S/ZnS quantum dots and their chlorotoxin-modified micelles for brain tumor cell targeting. RSC Adv 74 (2015), 60612–60620.
165. 165 Costa, P.M., Cardoso, A.L., Custódia, C., Cunha, P., de Almeida, L.P., de Lima, M.C.P., MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastoma. J Control Release 207 (2015), 31–39.
166. 166 Gao, H.L., Yang, Z., Cao, S.J., Xiong, Y., Zhang, S., Pang, Z.Q., et al. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterials 35 (2014), 2374–2382.
167. 167 Gao, H.L., Xiong, Y., Zhang, S., Yang, Z., Cao, S.J., Jiang, X.G., RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Mol Pharm 11 (2014), 1042–1052.
168. 168 Gao, H.L., Hu, Y., Xiong, Y., Zhang, S., Yang, J.R., Yu, L., et al. Glioma targeting and anti-glioma effect of interleukin 13 peptide and RGD peptide dual functionalized nanoparticles. Curr Pharm Biotechnol 14 (2013), 1118–1126.
169. 169 Vinters, H.V., Gilbert, J.J., Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14 (1983), 924–928.
170. 170 Agyare, E.K., Jaruszewski, K.M., Curran, G.L., Rosenberg, J.T., Grant, S.C., Lowe, V.J., et al. Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits. J Control Release 185 (2014), 121–129.
171. 171 Luther, T., Flössel, C., Mackman, N., Bierhaus, A., Kasper, M., Albrecht, S., et al. Tissue factor expression during human and mouse development. Am J Pathol 149 (1996), 101–113.
172. 172 Gao, H.L., Pan, S.Q., Yang, Z., Cao, S.J., Chen, C., Jiang, X.G., et al. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 32 (2011), 8669–8675.
173. 173 Chung, N.S., Wasan, K.M., Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev 56 (2004), 1315–1334.
174. 174 Li, J.W., Feng, L., Fan, L., Zha, Y., Guo, L.R., Zhang, Q.Z., et al. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials 32 (2011), 4943–4950.
175. 175 Gao, H.L., Qian, J., Cao, S.J., Yang, Z., Pang, Z.Q., Pan, S.Q., et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 33 (2012), 5115–5123.
176. 176 Gao, H.L., Yang, Z., Zhang, S., Pang, Z.Q., Liu, Q.F., Jiang, X.G., Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays. Acta Biomater 10 (2014), 858–867.
177. 177 Townsend, M., Mehta, T., Selkoe, D.J., Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282 (2007), 33305–33312.
178. 178 Allaman, I., Gavillet, M., Bélanger, M., Laroche, T., Viertl, D., Lashuel, H.A., et al. Amyloid-β aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30 (2010), 3326–3338.
179. 179 Bartnik, D., Funke, S.A., Andrei-Selmer, L.C., Bacher, M., Dodel, R., Willbold, D., Differently selected D-enantiomeric peptides act on different Aβ species. Rejuvenation Res 13 (2010), 202–205.
180. 42-binding D-enantiomeric peptides in transgenic AD mouse models. ChemMedChem 4 (2009), 276–282.
181. 181 Zhang, C., Wan, X., Zheng, X.Y., Shao, X.Y., Liu, Q.F., Zhang, Q.Z., et al. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer׳s disease mice. Biomaterials 35 (2014), 456–465.
182. 182 Zhang, C., Zheng, X.Y., Wan, X., Shao, X.Y., Liu, Q.F., Zhang, Z.M., et al. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer׳s disease. J Control Release 192 (2014), 317–324.
183. 183 Nie, Y., Schaffert, D., Rödl, W., Ogris, M., Wagner, E., Günther, M., Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy. J Control Release 152 (2011), 127–134.
184. 184 Xu, Q., Liu, Y.X., Su, S.S., Li, W., Chen, C.Y., Wu, Y., Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials 33 (2012), 1627–1639.
185. 185 Zhang, P.C., Hu, L.J., Yin, Q., Feng, L.Y., Li, Y.P., Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood–brain barrier penetration and glioma targeting therapy. Mol Pharm 9 (2012), 1590–1598.
186. 186 Li, Y., He, H., Jia, X.R., Lu, W.L., Lou, J.N., Wei, Y., A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 33 (2012), 3899–3908.
187. 187 He, H., Li, Y., Jia, X.R., Du, J., Ying, X., Lu, W.L., et al. PEGylated poly(amidoamine) dendrimer–based dual-targeting carrier for treating brain tumors. Biomaterials 32 (2011), 478–487.
188. 188 Ying, X., Wen, H., Lu, W.L., Du, J., Guo, J., Tian, W., et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 141 (2010), 183–192.
189. 189 Byeon, H.J., Thao le, Q., Lee, S., Min, S.Y., Lee, E.S., Shin, B.S., et al. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. J Control Release 225 (2016), 301–313.
190. 190 Yan, H.H., Wang, J.Y., Yi, P.W., Lei, H., Zhan, C.Y., Xie, C., et al. Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood–brain barrier. Chem Commun (Camb) 47 (2011), 8130–8132.
191. 191 Yang, Z.Z., Li, J.Q., Wang, Z.Z., Dong, D.W., Qi, X.R., Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Biomaterials 35 (2014), 5226–5239.
192. 192 Chen, Y.C., Chiang, C.F., Chen, L.F., Liang, P.C., Hsieh, W.Y., Lin, W.L., Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell–targeting delivery system. Biomaterials 35 (2014), 4066–4081.
193. 193 Gao, J.Q., Lv, Q., Li, L.M., Tang, X.J., Li, F.Z., Hu, Y.L., et al. Glioma targeting and blood–brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials 34 (2013), 5628–5639.
194. 194 Li, X.Y., Zhao, Y., Sun, M.G., Shi, J.F., Ju, R.J., Zhang, C.X., et al. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Biomaterials 35 (2014), 5591–5604.
195. 195 Yue, P.J., He, L., Qiu, S.W., Li, Y., Liao, Y.J., Li, X.P., et al. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Mol Cancer, 13, 2014, 191.
196. 196 Kuo, Y.C., Chen, Y.C., Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. Int J Pharm 479 (2015), 138–149.
197. 197 Zhang, J., Chen, N., Wang, H., Gu, W., Liu, K., Ai, P.H., et al. Dual-targeting superparamagnetic iron oxide nanoprobes with high and low target density for brain glioma imaging. J Colloid Interface Sci 469 (2016), 86–92.
198. 198 Bana, L., Minniti, S., Salvati, E., Sesana, S., Zambelli, V., Cagnotto, A., et al. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain barrier: implications for therapy of Alzheimer disease. Nanomedicine 10 (2014), 1583–1590.
199. 199 Sonali, Agrawal P., Singh, R.P., Rajesh, C.V., Singh, S., Vijayakumar, M.S., et al. Transferrin receptor–targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv 23 (2016), 1788–1798.
200. 200 Gao, X.H., Qian, J., Zheng, S.Y., Xiong, Y., Man, J.H., Cao, B.X., et al. Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect. Pharm Res 30 (2013), 2538–2548.
201. 201 Pardridge, W.M., Blood–brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody. Expert Opin Drug Deliv 12 (2015), 207–222.
202. 202 Maletínská, L., Blakely, E.A., Bjornstad, K.A., Deen, D.F., Knoff, L.J., Forte, T.M., Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res 60 (2000), 2300–2303.
203. 203 Ito, S., Ohtsuki, S., Terasaki, T., Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1–40) across the rat blood–brain barrier. Neurosci Res 56 (2006), 246–252.
204. 204 Li, H.Y., Qian, Z.M., Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 22 (2002), 225–250.
205. 205 Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R., et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 324 (2008), 1064–1072.
206. 206 Xin, H.L., Sha, X.Y., Jiang, X.Y., Chen, L.C., Law, K., Gu, J.J., et al. The brain targeting mechanism of angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. Biomaterials 33 (2012), 1673–1681.
207. 207 Xin, H.L., Jiang, X.Y., Gu, J.J., Sha, X.Y., Chen, L.C., Law, K., et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32 (2011), 4293–4305.
208. 208 Sun, X.Y., Pang, Z.Q., Ye, H.X., Qiu, B., Guo, L.R., Li, J.W., et al. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials 33 (2012), 916–924.
209. 209 Ni, D.L., Zhang, J.W., Bu, W.B., Xing, H.Y., Han, F., Xiao, Q.F., et al. Dual-targeting upconversion nanoprobes across the blood brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano 8 (2014), 1231–1242.
210. 210 Ruan, S.B., Yuan, M.Q., Zhang, L., Hu, G.L., Chen, J.T., Cun, X.L., et al. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials 37 (2015), 425–435.
211. 211 Su, Z.G., Xing, L., Chen, Y.N., Xu, Y.R., Yang, F.F., Zhang, C., et al. Lactoferrin-modified poly(ethylene glycol)–grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharm 11 (2014), 1823–1834.
212. 212 Wiley, D.T., Webster, P., Gale, A., Davis, M.E., Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc Natl Acad Sci U S A 110 (2013), 8662–8667.
213. 213 Du, D., Chang, N.D., Sun, S.L., Li, M.H., Yu, H., Liu, M.F., et al. The role of glucose transporters in the distribution of p-aminophenyl-α-D-mannopyranoside modified liposomes within mice brain. J Control Release 182 (2014), 99–110.
214. 214 Hao, Z.F., Cui, Y.X., Li, M.H., Du, D., Liu, M.F., Tao, H.Q., et al. Liposomes modified with P-aminophenyl-α-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice. Eur J Pharm Biopharm 84 (2013), 505–516.
215. 215 Jiang, X.Y., Xin, H.L., Ren, Q.Y., Gu, J.J., Zhu, L.J., Du, F.Y., et al. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials 35 (2014), 518–529.
216. 216 Kharya, P., Jain, A., Gulbake, A., Shilpi, S., Jain, A., Hurkat, P., et al. Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting. J Nanopart Res 15 (2013), 2022–2026.
217. 217 Elfinger, M., Maucksch, C., Rudolph, C., Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials 28 (2007), 3448–3455.
218. 218 Legrand, D., Pierce, A., Elass, E., Carpentier, M., Mariller, C., Mazurier, J., Lactoferrin structure and functions. Adv Exp Med Biol 606 (2008), 163–194.
219. 219 Liu, Z.Y., Jiang, M.Y., Kang, T., Miao, D.Y., Gu, G.Z., Song, Q.X., et al. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials 34 (2013), 3870–3881.
220. 220 Plate, K.H., Breier, G., Millauer, B., Ullrich, A., Risau, W., Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53 (1993), 5822–5827.
221. 221 Fan, C.H., Ting, C.Y., Liu, H.L., Huang, C.Y., Hsieh, H.Y., Yen, T.C., et al. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 34 (2013), 2142–2155.
222. 222 Wang, F., Wang, Y.C., Dou, S., Xiong, M.H., Sun, T.M., Wang, J., Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 5 (2011), 3679–3692.
223. 223 Shao, K., Ding, N., Huang, S.X., Ren, S.M., Zhang, Y., Kuang, Y.Y., et al. Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. ACS Nano 8 (2014), 1191–1203.
224. 224 Wu, G.Y., Fang, Y.Z., Yang, S., Lupton, J.R., Turner, N.D., Glutathione metabolism and its implications for health. J Nutr 134 (2004), 489–492.
225. 225 Shilo, M., Sharon, A., Baranes, K., Motiei, M., Lellouche, J.P., Popovtzer, R., The effect of nanoparticle size on the probability to cross the blood–brain barrier: an in-vitro endothelial cell model. J Nanobiotechnology, 13, 2015, 19.
226. 3-expressing tumor endothelial cells. Biomaterials 34 (2013), 5617–5627.
227. 227 Hirsjärvi, S., Sancey, L., Dufort, S., Belloche, C., Vanpouille-Box, C., Garcion, E., et al. Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting. Int J Pharm 453 (2013), 594–600.
228. 228 Popović, Z., Liu, W.H., Chauhan, V.P., Lee, J., Wong, C., Greytak, A.B., et al. A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl 49 (2010), 8649–8652.
229. 229 Zan, M.H., Li, J.J., Luo, S.Z., Ge, Z.S., Dual pH-triggered multistage drug delivery systems based on host-guest interaction-associated polymeric nanogels. Chem Commun (Camb) 50 (2014), 7824–7827.
230. 230 Ruan, S.B., Cao, X., Cun, X.L., Hu, G.L., Zhou, Y., Zhang, Y.J., et al. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. Biomaterials 60 (2015), 100–110.
231. 231 Ruan, S.B., He, Q., Gao, H.L., Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. Nanoscale 7 (2015), 9487–9496.
232. 232 Rolland, J.P., Maynor, B.W., Euliss, L.E., Exner, A.E., Denison, G.M., et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J Am Chem Soc 127 (2005), 10096–10100.
233. 233 Nel, A.E., Mädler, L., Velegol, D., Xia, T., Hoek, E.M.V., Somasundaran, P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8 (2009), 543–557.
234. 234 Aggarwal, P., Hall, J.B., McLeland, C.B., Dobrovolskaia, M.A., McNeil, S.E., Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61 (2009), 428–437.
235. 235 Salvati, A., Pitek, A.S., Monopoli, M.P., Prapainop, K., Bombelli, F.B., Hristov, D.R., et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8 (2013), 137–143.
236. 236 Mirshafiee, V., Mahmoudi, M., Lou, K.Y., Cheng, J.J., Kraft, M.L., Protein corona significantly reduces active targeting yield. Chem Commun (Camb) 49 (2013), 2557–2559.
237. 237 Ponka, P., Lok, C.N., The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 31 (1999), 1111–1137.
238. 238 Xie, R., Dong, L., Du, Y.F., Zhu, Y.T., Hua, R., Zhang, C., et al. In vivo metabolic labeling of sialoglycans in the mouse brain by using a liposome-assisted bioorthogonal reporter strategy. Proc Natl Acad Sci U S A 113 (2016), 5173–5178.